Does brachytherapy boost improve survival outcomes in Gleason Grade Group 5 patients treated with external beam radiotherapy and androgen deprivation therapy? A systematic review and meta-analysis.

Clin Transl Radiat Oncol · 2023 · PMC9637706 · PMID 36353652

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

showed a trendno p-value reported

A larger, single institutional retrospective review also showed a trend towards lower rates of toxicity with HDR-BT versus LDR-BT boost, though this did not reach statistical significance [48] .

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.